Elucidating the Molecular Determinants of the Binding Modes of a Third-Generation HIV-1 Integrase Strand Transfer Inhibitor: The Importance of Side Chain and Solvent Reorganization [PDF]
Qinfang Sun +4 more
openalex +1 more source
HIV‐1 reverse transcriptase and integrase enzymes physically interact and inhibit each other [PDF]
Taurai Tasara +3 more
openalex +1 more source
Latest advances in the efficacy, tolerability, and monotherapy of integrase inhibitors
Qi Tang, Hongzhou Lu
openalex +2 more sources
DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]
Anderson D +8 more
europepmc +1 more source
An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1. [PDF]
Evitt LA +5 more
europepmc +1 more source
Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non-case study from the global pharmacovigilance database VigiBase®. [PDF]
Saint-Lary L +3 more
europepmc +1 more source
HIV-1 Genetic Diversity and Natural Polymorphisms of the Integrase Gene in Integrase Inhibitor-Naive Patients in Harare, Zimbabwe. [PDF]
Madyadi A +7 more
europepmc +1 more source
Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy. [PDF]
Januszka J +4 more
europepmc +1 more source
Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor-Based Three-Drug Antiretroviral Therapy. [PDF]
Gerber A +3 more
europepmc +1 more source

